home / stock / mrtx / mrtx news


MRTX News and Press, Mirati Therapeutics Inc. From 06/04/19

Stock Information

Company Name: Mirati Therapeutics Inc.
Stock Symbol: MRTX
Market: NASDAQ
Website: mirati.com

Menu

MRTX MRTX Quote MRTX Short MRTX News MRTX Articles MRTX Message Board
Get MRTX Alerts

News, Short Squeeze, Breakout and More Instantly...

MRTX - GOGL, GTXI among premarket gainers

Castor Maritime (NASDAQ: CTRM ) +112%  on 1H results . More news on: Castor Maritime Inc., Attis Industries, Inc., Proteostasis Therapeutics, Inc., Stocks on the move, Read more ...

MRTX - Healthcare and Tech dominate midday movers

Gainers:  Genocea Biosciences (NASDAQ: GNCA ) +45% . Mirati Therapeutics (NASDAQ: MRTX ) +34% . Cypress Semiconductor (NASDAQ: CY ) +25% . ARCA biopharma (NASDAQ: ABIO ) +23% . Centrus Energy (NYSEMKT: LEU ) +18% . Spirit MTA REIT (NYSE: SMTA ) +18% . El Paso Electric (NYSE: EE ...

MRTX - Mirati up 32% on Amgen's KRAS inhibitor data

Mirati Therapeutics ( MRTX +32.4% ) is up on over 40% higher volume in apparent response to Phase 1 data on Amgen's KRAS G12C  inhibitor AMG 510 presented at ASCO in Chicago. More news on: Mirati Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

MRTX - American Society Of Clinical Oncology: A Biotech Friendly Event In An Unfriendly Healthcare Market

Market Pulse The month of May thus far has been mostly a downward ride with an occasional rise, proving to be a mere bunny bump, as indexes have eroded persistently on the lack of a trade resolution with China, an outcome that at one point was considered to be almost in the bag. This is rais...

MRTX - Mirati Therapeutics To Present At Jefferies 2019 Global Healthcare Conference

SAN DIEGO , May 30, 2019 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will present at the Jefferies Annual Global Healthcare Conference in New York on Thursday, June 6 th at 2:00 p.m. ET / 11:00 a.m. PT . Charles M. Bau...

MRTX - High Short Interest, Strong Performance Stocks: May 2019

Higher short interest is an odd indicator in the market. On one hand, it's a good indicator of sentiment as a high level generally suggests skepticism of the company's outlook, bringing bears to expect eventually lower share prices. It's also a poor indicator because significant levels of shor...

MRTX - 3 Gene Therapy Stocks For A Biotech Portfolio

Biotech Pulse The Nasdaq Biotech ( IBB ) and the S&P Biotech ( XBI ) indexes have struggled since March as the broader healthcare sector ( XLV ) declined following growing momentum amongst the presidential candidates for a universal healthcare plan. This was at a time when the broader ma...

MRTX - Microcaps mostly among midday movers

Gainers:  Eltek (NASDAQ: ELTK ) +70% . Iovance Biotherapeutics (NASDAQ: IOVA ) +33% . Adverum Biotechnologies (NASDAQ: ADVM ) +25% . Charah Solutions (NYSE: CHRA ) +19% . KEMET Corporation (NYSE: KEM ) +17% . Mirati Therapeutics (NASDAQ: MRTX ) +16% . Danaos Corporation (NYSE: D...

MRTX - GEVO, TRQ among premarket gainers

Iovance Biotherapeutics (NASDAQ: IOVA ) +36%  on positive TIL data . More news on: Iovance Biotherapeutics, Inc., CUI Global, Inc., MacroGenics, Inc., Stocks on the move, Read more ...

MRTX - Mirati fortunes with KRAS inhibitor tied to Amgen's - JPMorgan

JPMorgan analyst Anupam Rama says Mirati Therapeutics ( MRTX +1% ) may experience volatility related to Amgen's ( AMGN +0.5% ) fortunes with pipeline candidate AMG 510, in early-stage development for certain types of cancer. More news on: Mirati Therapeutics, Inc., Amgen Inc....

Previous 10 Next 10